Pacira BioSciences (PCRX) Deferred Taxes (2020 - 2026)

Pacira BioSciences' Deferred Taxes history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Deferred Taxes rose 23.84% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.8 million (down 63.3% YoY), while the FY2025 annual figure was $6.5 million, down 68.59% from the prior year.
• Deferred Taxes was $1.7 million for Q1 2026 at Pacira BioSciences, up from -$3.7 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $12.5 million in Q2 2024 to a low of -$10.8 million in Q4 2022.
• Historically, Deferred Taxes has averaged $2.1 million across 5 years, with a median of $1.7 million in 2026.
• The sharpest annual moves came in 2023 and 2025: Deferred Taxes slumped 25417.24% in 2023, then surged 623.95% in 2025.
• A 5-year view of Deferred Taxes shows it stood at -$10.8 million in 2022, then jumped by 160.89% to $6.6 million in 2023, then tumbled by 46.86% to $3.5 million in 2024, then plunged by 206.73% to -$3.7 million in 2025, then surged by 146.21% to $1.7 million in 2026.
• The last three Deferred Taxes figures came in at $1.7 million (Q1 2026), -$3.7 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.